Novartis announced this week that the FDA has approved ribociclib (marketed as Kisqali) for the treatment of people with ...

The Swedish biotech company Cellevate has raised €3.2 million in a seed round to fuel the commercialization of its ...

The new company focuses on producing components needed to manufacture RNA-based therapies for which there is increasing ...

With a new investment in its two manufacturing sites in Ireland, Eli Lilly continues implementing the largest expansion ...

MinervaX and Wacker Biotech announced yesterday that they have entered into a manufacturing agreement for MinervaX’s ...

The original concerns of the US regulatory agency over the manufacturing of Eli Lilly’s Ebglyss seem to have been resolved, ...

The FDA has granted Orphan Drug and Rare Pediatric Disease Designations to Somite’s cell replacement therapy for the ...

Rachel Sha has had a colorful career not without its challenges, but she urges women in the science industry to have ...

The San Diego-based biotech company Candid Therapeutics has launched with a huge $370 million with the aim to develop T-cell ...

Rare disease biotech Rezolute recently announced that the FDA has lifted the partial clinical hold on RZ358 (ersodetug), a ...

Adaptin Bio has announced that the FDA has given the green light to start phase 1 clinical trials for its program APTN-101 ...

The European Commission has granted Orphan Drug Designation for Vivet Therapeutics’ gene therapy product VTX-806 for the ...